Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Sierra Sun Times1d
UC San Francisco on New RSV Vaccine and Updated Vaccine Guidance for Seniors
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
KSL1d
FDA lifts clinical hold on Novavax's combo COVID-flu shot
The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
Benzinga.com2d
FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
Also Read: DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals ... Novavax is scheduled to release its third-quarter earnings tomorrow, Tuesday.
The major COVID variants we've seen so far and which one to look out for right now
Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Barclays Lowers Moderna (NASDAQ:MRNA) Price Target to $111.00
Moderna (NASDAQ:MRNA – Get Free Report) had its price objective dropped by research analysts at Barclays from $125.00 to $111 ...
GEN3d
StockWatch: Wall Street Weighs Trump Effect on Biopharma, from Vaccines to M&A
reported its third-quarter earnings. Even though the company surprised analysts by reporting net income of $13 million (up ...
marketinference4d
Shares of Moderna Are Down -6.9% -- Are They Valued Fairly?
Standing out among the Street's worst performers today is Moderna, a biotechnology company whose shares slumped -6.9% to a ...
2 Biotech Stocks You Can Buy Hand Over Fist This Month
Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...